Web Page

Drug Safety Communications - FDA warns about dental problems with buprenorphine medicines dissolved in the mouth to treat opioid use disorder and pain

This is an FDA warning that dental problems have been reported with medicines containing buprenorphine that are dissolved in the mouth. Despite these risks, buprenorphine is an important treatment option for opioid use disorder (OUD) and pain, and the benefits of these medicines clearly outweigh the risks.

The Telehealth Era is Just Beginning

Describes the process for adoption of telehealth for patient care inside Kaiser Permanente and Intermountain Healthcare, showing the benefits of telehealth in reducing expensive and unnecessary trips to hospitals, how it can make care safer and more efficient and address disparities in care, and discussing what is needed to help other health systems adopt this new technology